摘要
目的:探讨生长抑素联合乌司他丁治疗急性重症胰腺炎的临床疗效。方法:将笔者所在医院2009年-2011年间收治的84例急性重症胰腺炎患者随机分为观察组和对照组,每组42例,对照组患者采用生长抑素治疗,观察组患者采用生长抑素联合乌司他丁治疗,比较两组患者的临床疗效。结果:观察组42例患者治疗后显效35例(83.3%),有效5例(11.9%),无效2例(4.8%),治疗总有效率为95.2%,显著高于对照组的76.2%,组间差异有统计学意义(P<0.05)。结论:生长抑素联合乌司他丁治疗急性重症胰腺炎临床疗效确切,值得临床进一步推广使用。
Objective： To investigate the effects of somatostatin combined with ulinastatin in the treatment of acute severe pancreatitis.Methods： 84 patients withacute severe pancreatitis in Huiyang district people＇s hospital from 2009 to 2011 years were randomly divided into observation group and control group, 42 cases in each group, patients in the control group were treated with somatostatin treatment, patients in the observation group were treated by somatostatin combined with ulinastatin treatment, compared clinical curative effect of patients in two groups. Results： 42 patients in the observation group, cured in 35 cases （83.3%）, effective in 5 cases （11.9%）, invalid in 2 cases（4.8%）, the total effective rate was 95.2%, significantly higher than that in control group 76.2%, the difference between two groups was statistically significant （P〈0.05）. Conclusion： Taking somatostatin combined with ulinastatin treatment in acute severe pancreatitis has good clinical curative effect, it is worthy of further clinical using.
出处
《中外医学研究》
2013年第2期13-14,共2页
CHINESE AND FOREIGN MEDICAL RESEARCH
关键词
急性重症胰腺炎
生长抑素
乌司他丁
疗效
Acute severe pancreatitis
Somatostatin
Ulinastatin
Curative effect
